More on ZYME

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-1,333.3% Growth)
- Ratings (9.5 Score)
- Holders

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Zymeworks (NQ:ZYME)
Delayed: 22.86 --0 (-0%)
Prev. Close $22.86  
Open$22.86 
52 Wk High$ 
52 Wk Low$ 
Day High$22.86 
Day Low$22.86 
P/E N/A  
EPS$ 
Volume2 

Friends, Peers and Foes (?): TBPH, RPRX, GLMD, RPTX, INM (more...)

Jul 16, 2026 06:00 AM Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
Jul 7, 2026 07:37 AM H.C. Wainwright Downgrades Theravance Biopharma (TBPH) to Neutral
Jul 7, 2026 07:09 AM Zymeworks (ZYME) PT Raised to $31 at Truist Securities
Jul 6, 2026 05:29 PM Form 4 Zymeworks Inc. For: Jul 06 Filed by: Hollywood Mark
Jun 29, 2026 10:27 AM B. Riley: 'Aggressively Buying the ZYME Dip'
Jun 29, 2026 09:20 AM BTIG Downgrades Theravance Biopharma (TBPH) to Neutral
Jun 29, 2026 08:34 AM Jones Trading Downgrades Theravance Biopharma (TBPH) to Hold
Jun 29, 2026 07:20 AM Form 8-K Zymeworks Inc. For: Jun 28
Jun 29, 2026 07:19 AM Zymeworks (ZYME) Reiterated at Buy by Stifel: 'Significantly Undervalued'
Jun 29, 2026 06:00 AM Zymeworks to buy Theravance Biopharma for $17 per share
View All Articles

Entities mentioned with ZYME

View All Entities